Tokyo - Delayed Quote JPY

CellSource Co., Ltd. (4880.T)

1,505.00 -12.00 (-0.79%)
As of 9:38 AM GMT+9. Market Open.
Advanced Chart
Loading Chart for 4880.T
DELL
  • Previous Close 1,517.00
  • Open 1,509.00
  • Bid --
  • Ask --
  • Day's Range 1,497.00 - 1,526.00
  • 52 Week Range 1,179.00 - 3,180.00
  • Volume 22,100
  • Avg. Volume 201,470
  • Market Cap (intraday) 29.807B
  • Beta (5Y Monthly) 0.25
  • PE Ratio (TTM) 34.21
  • EPS (TTM) 43.99
  • Earnings Date Jun 12, 2024 - Jun 17, 2024
  • Forward Dividend & Yield 10.00 (0.66%)
  • Ex-Dividend Date Oct 30, 2024
  • 1y Target Est 1,800.00

CellSource Co., Ltd. engages in the regenerative medicine-related businesses in Japan. The company provides processing services to extract adipose-derived stem cells from patients' adipose tissues, and to prepare platelet-rich plasma from patients' blood; and offers support services for medical facilities providing regenerative medicine therapy, as well as manufacturing processed cells. It is also involved in the development and sale of Signalift series of anti-aging products, including a serum. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

www.cellsource.co.jp

151

Full Time Employees

October 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about CellSource Co., Ltd.

Related News

View More
View More

Performance Overview: 4880.T

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

4880.T
17.67%
Nikkei 225
12.24%

1-Year Return

4880.T
40.67%
Nikkei 225
32.18%

3-Year Return

4880.T
63.89%
Nikkei 225
28.96%

5-Year Return

4880.T
--
Nikkei 225
63.50%

Compare To: 4880.T

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

4880.T
CellSource Co., Ltd.
1,505.00
-0.79%
Mkt Cap JPY 29.807B
Industry Biotechnology
GENO.ST
Genovis AB (publ.)
25.95
-3.53%
Mkt Cap SEK 1.699B
Industry Biotechnology
TECH
Bio-Techne Corporation
62.66
-1.35%
Mkt Cap 9.85B
Industry Biotechnology

Statistics: 4880.T

View More

Valuation Measures

Annual
As of 4/25/2024

  • Market Cap

    30.04B

  • Enterprise Value

    25.36B

  • Trailing P/E

    34.54

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.37

  • Price/Book (mrq)

    5.04

  • Enterprise Value/Revenue

    5.48

  • Enterprise Value/EBITDA

    22.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.38%

  • Return on Assets (ttm)

    11.98%

  • Return on Equity (ttm)

    17.06%

  • Revenue (ttm)

    4.62B

  • Net Income Avi to Common (ttm)

    850M

  • Diluted EPS (ttm)

    43.99

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.68B

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: 4880.T

View More

Analyst Price Targets

1,800.00
1,800.00 Average
1,505.00 Current
1,800.00 High
 

Fair Value

 
View More

Company Insights: 4880.T

People Also Watch

7685.T BuySell Technologies Co.,Ltd.
2,779.00
+1.79%
 
4449.T giftee Inc.
1,178.00
-2.40%
 
2471.T S-Pool, Inc.
301.00
-0.66%
 
2160.T GNI Group Ltd.
2,443.00
+0.08%
 
6035.T IR Japan Holdings, Ltd.
1,173.00
-0.25%
 
4974.T Takara Bio Inc.
1,002.00
-1.18%
 
4599.T StemRIM
435.00
0.00%
 
4595.T Mizuho Medy Co.,Ltd.
3,275.00
-1.36%
 
7839.T Shoei Co., Ltd.
2,180.00
-2.94%
 
3697.T SHIFT Inc.
14,475.00
-2.43%
 
4587.T PeptiDream Inc.
1,602.00
+0.41%
 
4565.T Nxera Pharma Co., Ltd.
1,484.00
-0.74%
 
4592.T SanBio Company Limited
414.00
+0.24%
 
2491.T ValueCommerce Co., Ltd.
1,033.00
+0.88%
 
4475.T Hennge K.K.
1,027.00
-0.96%
 
4483.T JMDC Inc.
3,193.00
-1.63%